Neurocrine Biosciences Inc (NBIX) operating KPIs
NBIXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 31, 2026Score 19/3018% below fair value
$146.10−0.28 (-0.19%)
Close on Oct 30, 2026Market cap $14.85BP/E 21.4Yield –
KPIs
Operating metrics that drive Neurocrine Biosciences's business
Coming soon
This tab will track the numbers specific to Neurocrine Biosciences's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.